Array
(
[a_id] => 288666
[c_id] => 14
[r_id] => 0
[rr_id] => 0
[m_id] => 0
[s_id] => 25646
[id_id] => 0
[v_id] => 0
[loc_id] => 0
[ft_id] => 0
[a_classification] => news
[a_layout] => 1
[a_headline] => Autism 'Reversed' In Mice For 5 Weeks, Thanks To 100-Year-Old Sleeping Sickness Drug
[a_sheadline] => A Century-Old Sleeping Sickness Drug Reversed Autism Signs In Mice
[a_slug] => autism-reversed-mice-5-weeks-thanks-100-year-old-sleeping-sickness-drug-288666
[a_subheadline] =>
[a_summary] => Geneticists managed to reverse autism-like behaviors in mice for five weeks, although human trials may prove more difficult.
[a_article] =>
Geneticists from the University of California, San Diego, managed to reverse signs of autism in lab mice with help from a century-old African sleeping sickness drug, called suramin, a new study reports.
Building upon prior research into the complex interplay between genetics and the environment, the team found that attacking cells’ biology worked to produce key environmental changes in mice. These cellular changes ultimately reversed the animals’ reclusive, avoidant behaviors for just over a month. While incomparable to human models, which still demand clinical trials, the team believes their findings belie the assumption that autism is somehow permanent.
"Twenty percent of the known factors associated with autism are genetic, but most are not,” said Dr. Robert Naviaux, senior author and professor of medicine, pediatrics, and pathology, in a statement. “It's wrong to think of genes and the environment as separate and independent factors. Genes and environmental factors interact. The net result of this interaction is metabolism."
One of the telltale signs of autism, when looking at a cell, is its number of metabolic disturbances. Surrounding each cell in the body is a ring of metabolites and nucleotides. These substances broadly serve to regulate metabolism in the body. But when microbes or bacteria, threats to the cell, confront these metabolites, the cell’s outer layer stiffens. Communication between cells starts to degrade. Collectively, this process is known as the cell danger response.
"Cells behave like countries at war," Naviaux said. When there’s a threat, walls go up and countries stop communicating. In the case of neurons, he explains, this may mean fewer or too many connections. “One way to look at this related to autism is this: When cells stop talking to each other, children stop talking."
In the United States, because of a mix of genetic, environmental, or lifestyle factors, the autism rate in children is ascending with a troubling velocity. In the year 2000, the rate was roughly one in 150 children. By 2010, the rate had increased to one in 68. Boys are especially prone to autism diagnoses, as the rate pales in comparison to girls: one in 42 versus one in 189. Scientists have yet to pin down a conclusive cause — it’s likely an amalgam of many factors working together, Naviaux suspects — and research on the disorder, while robust, hasn’t bore much fruit.
In 2013, Naviaux authored a study that found that mice at 6 weeks old (15 years by human standards) saw a dramatic slide in autism-like symptoms when their cell danger response persisted. In his team’s latest study, mice at 6 months old (30 years) displayed the same behavior. But when they introduced suramin, which has been in use since the 20th century as a way to kill organisms responsible for African sleeping sickness, the mice’s autistic behavior stopped. Mazes no longer seemed unappealing. They joined other mice. Seventeen of the 18 major pathways that had been disrupted by the danger response had corrected or improved.
Migrating the drug from mice to humans isn’t so simple, however. Rodent tests far too often fail once they reach the human stage, for the sole reason that mice aren’t people. Our brains aren’t identical. Injecting prolonged doses of suramin into children, for instance, would almost certainly result in sweeping anemia. Purinergic receptors, those that interact with many autism-like behaviors via cells, aren’t only affected by suramin, however. The findings imply that other compounds could yield the same effect if they target these receptors in safer ways — provided that smaller doses of suramin fail human trials.
“The discovery that a single dose of medicine can fundamentally reset metabolism for weeks means that newer and safer drugs might not need to be given chronically,” Naviaux said. “Members of this new class of medicines might need to be given only intermittently during sensitive developmental windows to unblock metabolism and permit improved development in response to many kinds of behavioral and occupational therapies, and to natural play."
Source: Naviaux J, Schuchbauer M, Li M, et al. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Translational Psychiatry. 2014.
Geneticists managed to reverse autism-like behaviors in mice for five weeks, although human trials may prove more difficult.Global Panorama, CC BY-SA 2.0
[a_content] =>
Geneticists from the University of California, San Diego, managed to reverse signs of autism in lab mice with help from a century-old African sleeping sickness drug, called suramin, a new study reports.
Building upon prior research into the complex interplay between genetics and the environment, the team found that attacking cells’ biology worked to produce key environmental changes in mice. These cellular changes ultimately reversed the animals’ reclusive, avoidant behaviors for just over a month. While incomparable to human models, which still demand clinical trials, the team believes their findings belie the assumption that autism is somehow permanent.
"Twenty percent of the known factors associated with autism are genetic, but most are not,” said Dr. Robert Naviaux, senior author and professor of medicine, pediatrics, and pathology, in a statement. “It's wrong to think of genes and the environment as separate and independent factors. Genes and environmental factors interact. The net result of this interaction is metabolism."
One of the telltale signs of autism, when looking at a cell, is its number of metabolic disturbances. Surrounding each cell in the body is a ring of metabolites and nucleotides. These substances broadly serve to regulate metabolism in the body. But when microbes or bacteria, threats to the cell, confront these metabolites, the cell’s outer layer stiffens. Communication between cells starts to degrade. Collectively, this process is known as the cell danger response.
"Cells behave like countries at war," Naviaux said. When there’s a threat, walls go up and countries stop communicating. In the case of neurons, he explains, this may mean fewer or too many connections. “One way to look at this related to autism is this: When cells stop talking to each other, children stop talking."
In the United States, because of a mix of genetic, environmental, or lifestyle factors, the autism rate in children is ascending with a troubling velocity. In the year 2000, the rate was roughly one in 150 children. By 2010, the rate had increased to one in 68. Boys are especially prone to autism diagnoses, as the rate pales in comparison to girls: one in 42 versus one in 189. Scientists have yet to pin down a conclusive cause — it’s likely an amalgam of many factors working together, Naviaux suspects — and research on the disorder, while robust, hasn’t bore much fruit.
In 2013, Naviaux authored a study that found that mice at 6 weeks old (15 years by human standards) saw a dramatic slide in autism-like symptoms when their cell danger response persisted. In his team’s latest study, mice at 6 months old (30 years) displayed the same behavior. But when they introduced suramin, which has been in use since the 20th century as a way to kill organisms responsible for African sleeping sickness, the mice’s autistic behavior stopped. Mazes no longer seemed unappealing. They joined other mice. Seventeen of the 18 major pathways that had been disrupted by the danger response had corrected or improved.
Migrating the drug from mice to humans isn’t so simple, however. Rodent tests far too often fail once they reach the human stage, for the sole reason that mice aren’t people. Our brains aren’t identical. Injecting prolonged doses of suramin into children, for instance, would almost certainly result in sweeping anemia. Purinergic receptors, those that interact with many autism-like behaviors via cells, aren’t only affected by suramin, however. The findings imply that other compounds could yield the same effect if they target these receptors in safer ways — provided that smaller doses of suramin fail human trials.
“The discovery that a single dose of medicine can fundamentally reset metabolism for weeks means that newer and safer drugs might not need to be given chronically,” Naviaux said. “Members of this new class of medicines might need to be given only intermittently during sensitive developmental windows to unblock metabolism and permit improved development in response to many kinds of behavioral and occupational therapies, and to natural play."
Source: Naviaux J, Schuchbauer M, Li M, et al. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Translational Psychiatry. 2014.
The study also revealed that individuals who quit smoking, regardless of age, can achieve a life expectancy similar to non-smokers within approximately 10 years after quitting, and nearly half of this benefit can be noticed within just three years.
Researchers found that a combination of genetics and environmental factors reduces longevity in dementia patients. The same combination may shorten the lives of their siblings even without dementia.
The suicide rates increase substantially when air pollution rises, and the effect was particularly strong in the elderly, with older women 2.5 times more at risk than other groups.
While mental stress is commonly acknowledged in connection with grief, it is crucial to understand that grief can also present physical symptoms, including illnesses, fatigue, pain, and sleep disturbances.
The use of antidepressants, particularly fluoxetine, could affect the development of the prefrontal cortex of the infant's brain, potentially raising the risk of mental health disorders later in their life.
Researchers have developed smart earrings that could continuously monitor a person's earlobe temperature. The innovation known as Thermal Earring could also be potentially used to track signs of ovulation, stress, eating, and exercise.
The researchers made the interesting finding using a trial involving patients with a rare genetic condition called Alpha-1 antitrypsin deficiency (AATD).
People infected with the flu were more likely to need hospital care in the following year for common neurologic conditions than people who had the SARS-CoV2 infection.
Among women with a history of pregnancy complications, those who achieved or maintained high heart health after pregnancy were at a similar risk for heart disease as women without adverse pregnancy outcomes and good cardiovascular health, the study stated.
The study published in the journal BMJ indicated that individuals with hypermobile joints had a 30% higher chance of not fully recovering from COVID-19 and experiencing persistent fatigue associated with long COVID.
The studies showed that COVID antigens lingered in the blood up to 14 months after infection and more than two years in tissue samples of people who had the infection.
Those individuals who receive a COVID-19 vaccine during the first half of their menstrual cycle are more likely to experience cycle length changes than those receiving a vaccine in the latter half.
The current booster dose is meant for older adults at least four months after a previous dose, or at least three months after a COVID-19 infection.
Autism 'Reversed' In Mice For 5 Weeks, Thanks To 100-Year-Old Sleeping Sickness Drug
By
Geneticists managed to reverse autism-like behaviors in mice for five weeks, although human trials may prove more difficult.Global Panorama, CC BY-SA 2.0
Geneticists from the University of California, San Diego, managed to reverse signs of autism in lab mice with help from a century-old African sleeping sickness drug, called suramin, a new study reports.
Building upon prior research into the complex interplay between genetics and the environment, the team found that attacking cells’ biology worked to produce key environmental changes in mice. These cellular changes ultimately reversed the animals’ reclusive, avoidant behaviors for just over a month. While incomparable to human models, which still demand clinical trials, the team believes their findings belie the assumption that autism is somehow permanent.
"Twenty percent of the known factors associated with autism are genetic, but most are not,” said Dr. Robert Naviaux, senior author and professor of medicine, pediatrics, and pathology, in a statement. “It's wrong to think of genes and the environment as separate and independent factors. Genes and environmental factors interact. The net result of this interaction is metabolism."
One of the telltale signs of autism, when looking at a cell, is its number of metabolic disturbances. Surrounding each cell in the body is a ring of metabolites and nucleotides. These substances broadly serve to regulate metabolism in the body. But when microbes or bacteria, threats to the cell, confront these metabolites, the cell’s outer layer stiffens. Communication between cells starts to degrade. Collectively, this process is known as the cell danger response.
"Cells behave like countries at war," Naviaux said. When there’s a threat, walls go up and countries stop communicating. In the case of neurons, he explains, this may mean fewer or too many connections. “One way to look at this related to autism is this: When cells stop talking to each other, children stop talking."
In the United States, because of a mix of genetic, environmental, or lifestyle factors, the autism rate in children is ascending with a troubling velocity. In the year 2000, the rate was roughly one in 150 children. By 2010, the rate had increased to one in 68. Boys are especially prone to autism diagnoses, as the rate pales in comparison to girls: one in 42 versus one in 189. Scientists have yet to pin down a conclusive cause — it’s likely an amalgam of many factors working together, Naviaux suspects — and research on the disorder, while robust, hasn’t bore much fruit.
In 2013, Naviaux authored a study that found that mice at 6 weeks old (15 years by human standards) saw a dramatic slide in autism-like symptoms when their cell danger response persisted. In his team’s latest study, mice at 6 months old (30 years) displayed the same behavior. But when they introduced suramin, which has been in use since the 20th century as a way to kill organisms responsible for African sleeping sickness, the mice’s autistic behavior stopped. Mazes no longer seemed unappealing. They joined other mice. Seventeen of the 18 major pathways that had been disrupted by the danger response had corrected or improved.
Migrating the drug from mice to humans isn’t so simple, however. Rodent tests far too often fail once they reach the human stage, for the sole reason that mice aren’t people. Our brains aren’t identical. Injecting prolonged doses of suramin into children, for instance, would almost certainly result in sweeping anemia. Purinergic receptors, those that interact with many autism-like behaviors via cells, aren’t only affected by suramin, however. The findings imply that other compounds could yield the same effect if they target these receptors in safer ways — provided that smaller doses of suramin fail human trials.
“The discovery that a single dose of medicine can fundamentally reset metabolism for weeks means that newer and safer drugs might not need to be given chronically,” Naviaux said. “Members of this new class of medicines might need to be given only intermittently during sensitive developmental windows to unblock metabolism and permit improved development in response to many kinds of behavioral and occupational therapies, and to natural play."
Source: Naviaux J, Schuchbauer M, Li M, et al. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Translational Psychiatry. 2014.
